Business

This panel will discuss sales of health care industry businesses where bondholders/lenders have an operator/borrower that is not performing. Topics to be covered include regulatory and licensing issues involved with a sale/transfer of facilities, insurance matters, and how patient care and creditors' rights can intersect (or collide).

This panel will identify the unique issues that come into play in health care asset sales, from hospitals to senior living facilities. The panelists will address closing challenges, regulatory issues, HIPPA/privacy issues, Opco/Propco issues and much more.

Hosted by Diversity, Equity and Inclusion & Young and New Members Committees Mentorship plays a pivotal role in fostering professional growth, nurturing talent and driving organizational success. From establishing meaningful mentor/mentee relationships to fostering a culture of continuous learning, this panel will explore practical approaches and best practices for harnessing the power of mentorship in the workplace.

Artificial Intelligence (AI) and machine learning have the potential to reshape the landscape of corporate restructurings and valuations by influencing the creation, protection, efficiencies and valuations of various asset classes. While AI presents opportunities for businesses to innovate, grow and protect their assets more effectively, it also brings new challenges and uncertainties that require careful consideration and adaptation. This panel discussion will address how AI might be used in corporate restructuring and valuation, and the potential benefits and risks.

Hosted by Financial Advisors and Investment Banking & Unsecured Trade Creditors Committees This panel will discuss the strategic use of valuation evidence throughout the life of a chapter 11 case, from financing and sale process to confirmation and fraudulent conveyance/other litigation.

Regional judges will strive to answer questions on current issues.

This panel will present a lively debate addressing current trends in DIP financing. Who are (and are not) DIP lenders these days? What opportunities and challenges arising from the amortization of Main Street lending programs should practitioners be aware of? How is DIP financing being used to buttress liability-management transactions? How big should a DIP loan be, and what issues arise in corporate governance when a company seeks a DIP? When do DIP protections go too far?